awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36794818-CC5147DF-1AA2-48E3-B411-8235C8BCB16B
Q36794818-CC5147DF-1AA2-48E3-B411-8235C8BCB16B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36794818-CC5147DF-1AA2-48E3-B411-8235C8BCB16B
Active and passive immunotherapy: vaccines and antibodies.
P2860
Q36794818-CC5147DF-1AA2-48E3-B411-8235C8BCB16B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36794818-CC5147DF-1AA2-48E3-B411-8235C8BCB16B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c2c7bdc9a5df9f41b14ad567757cf6e29cf2638
P2860
Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma.